Kangmai Life Sciences targets the Hong Kong Stock Exchange: T-cell connector field ranks second in global authorized transaction value, with a total value of external cooperation exceeding 2.1 billion US dollars.

According to the Wisdom Finance APP, it was disclosed by the Hong Kong Stock Exchange on June 24 that Anmicro Biotech Limited (referred to as Anmicro Biotech) submitted a listing application to the Hong Kong Stock Exchange, with joint sponsors being CITIC Securities and CMB International.